These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11096243

  • 21. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T, Chung J, Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS.
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma.
    Cássio Zequi Sd, Fregnani JH, Favaretto RL, Costa WH, Madeira Campos RS, Fonseca FP, Guimaraes GC, Soares FA, da Cunha IW, Lopes A.
    World J Urol; 2013 Oct; 31(5):1197-203. PubMed ID: 22562149
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases.
    Ficarra V, Righetti R, Pilloni S, D'amico A, Maffei N, Novella G, Zanolla L, Malossini G, Mobilio G.
    Eur Urol; 2002 Feb; 41(2):190-8. PubMed ID: 12074408
    [Abstract] [Full Text] [Related]

  • 29. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 32. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug 15; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
    Mouracade P, Dagenais J, Chavali JS, Kara O, Nelson RJ, Maurice MJ, Reese J, Rini BI, Kaouk JH.
    Clin Genitourin Cancer; 2018 Oct 15; 16(5):e1077-e1082. PubMed ID: 28818550
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, Hong SK.
    J Urol; 2006 Oct 15; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [Abstract] [Full Text] [Related]

  • 38. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.
    J Urol; 2009 May 15; 181(5):2027-32. PubMed ID: 19286201
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R.
    BJU Int; 2014 Aug 15; 114(2):210-5. PubMed ID: 24854206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.